Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others
- 94 Downloads
Hepatocellular carcinoma (HCC) is the sixth most common tumor worldwide [ 1]. Locoregional treatment choices for HCC include molecular-targeted chemotherapy, yttrium-90 radioembolization, and interventional radiological methods including transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) [ 2, 3]. Imaging has a very important role in the management of HCC and the efficacy of treatment is usually monitored and evaluated radiologically. Response to therapy has been evaluated by morphologic methods using different criteria such as the World Health Organization (WHO) criteria or the Response Evaluation Criteria in Solid Tumors (RECIST) in treatment (Table 1). However, the development of advanced therapies has required novel methods for evaluating response to treatment. This need has led to development of tumor- or therapy-specific guidelines such as the modified computed tomography (CT) Response Evaluation (Choi) Criteria for gastrointestinal...
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 6.Nishino M, Jackman DM, Hatabu H, Yeap BY, Cioffredi LA, Yap JT, et al. New response evaluation criteria in solid tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy. AJR am J Roentgenol. 2010;195:W221–8.CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Choi H, Charnsangavej C, Faria SC, et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinibmesylate: proposal of new computed tomography response criteria. J ClinOncol. 2007;25:1753–9.CrossRefGoogle Scholar
- 23.Park YS, Lee CH, Kim JH, Kim IS, Kiefer B, Seo TS, et al. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result. Magn Reson Imaging. 2014;32:638–46.CrossRefPubMedGoogle Scholar
- 28.Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging. 2004;19:598–604.CrossRefPubMedGoogle Scholar
© Springer Science+Business Media New York 2017